Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Capital Employed (2020 - 2025)

Pulmonx has reported Return on Capital Employed over the past 6 years, most recently at 47.7% for Q3 2025.

  • Quarterly Return on Capital Employed fell 934.0% to 47.7% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 47.7% through Sep 2025, down 934.0% year-over-year, with the annual reading at 39.56% for FY2024, 146.0% down from the prior year.
  • Return on Capital Employed was 47.7% for Q3 2025 at Pulmonx, down from 44.99% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 15.77% in Q1 2021 and troughed at 47.7% in Q3 2025.
  • The 5-year median for Return on Capital Employed is 34.56% (2023), against an average of 32.92%.
  • Year-over-year, Return on Capital Employed decreased -30bps in 2021 and then tumbled -1151bps in 2022.
  • A 5-year view of Return on Capital Employed shows it stood at 21.17% in 2021, then crashed by -54bps to 32.68% in 2022, then fell by -20bps to 39.14% in 2023, then decreased by -5bps to 41.02% in 2024, then dropped by -16bps to 47.7% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Return on Capital Employed are 47.7% (Q3 2025), 44.99% (Q2 2025), and 43.79% (Q1 2025).